The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer

Clinical Cancer Research

Volumn 8, Issue 11, 2002, Pages 3480-3486

  Inoshima, Naoko ^a   Nakanishi, Yoichi ^a   Minami, Takahiro ^a   Izumi, Miiru ^a   Takayama, Koichi ^a   Yoshino, Ichiro ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; BIOSYNTHESIS; CYTOLOGY; LUNG TUMOR; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PATHOLOGY; TIME; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DENDRITIC CELLS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROGNOSIS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036849944     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 43: 175-203, 1985.
2. Fox, S. B., Gatter, K. C., and Harris, A. L. Tumor angiogenesis. J. Pathol., 179: 232-237, 1996.
3. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
4. Tanigawa, N., Amaya, H., Matsumura, M., Shimomatsuya, T., Horiuchi, T., Muraoka, R., and Iki, M. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res., 56: 2671-2676, 1996.
5. Ogawa, Y., Chung, Y. S., Nakata, B., Takatsuka, S., Maeda, K., Sawada, T., Kato, Y., Yoshikawa, K., Sakurai, M., and Sowa, M. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br. J. Cancer, 71: 1297-1301, 1995.
6. Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F., and Angeletti, C. A. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet, 18: 145-146, 1992.
7. Yamazaki, K., Abe, S., Takekawa, H., Sukoh, N., Watanabe, N., Ogura, S., Nakajima, I., Isobe, H., Inoue, K., and Kawakami, Y. Tumor angiogenesis in human lung adenocarcinoma. Cancer (Phila.), 74: 2245-2250, 1994.
8. Ferrara, N., Houck, K., Jakeman, L., and Leung, D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev., 13: 18-32, 1992.
9. Samoto, K., Ikezaki, K., Ono, M., Shono, T., Kohno, K., Kuwano, M., and Fukui, M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res., 55: 1189-1193, 1995.
10. An, F. Q., Matsuda, M., Fujii, H., and Matsumoto, Y. Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol., 126: 153-160, 2000.
11. Yano, T., Tanikawa, S., Fujie, T., Masutani, M., and Horie, T. Vascular endothelial growth factor expression and neovascularization in non-small cell lung cancer. Eur. J. Cancer, 36: 601-609, 2000.
12. O'Byrne, K. J., Koukourakis, M. I., Giatromanolaki, A., Cox, G., Turley, H., Steward, W. P., Gatter, K., and Harris, A. L. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br. J. Cancer, 82: 1427-1432, 2000.
13. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9: 271-296, 1991.
14. Tsujitani, S., Kakeji, Y., Watanabe, A., Kohnoe, S., Maehara, Y., and Sugimachi, K. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer (Phila.), 66: 2012-2016, 1990.
15. Ambe, K., Mori, M., and Enjoji, M. S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer (Phila.), 63: 496-503, 1989.
16. Matsuda, H., Mori, M., Tsujitani, S., Ohno, S., Kuwano, H., and Sugimachi, K. Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein-positive cells in human malignant esophageal tissues. Cancer (Phila.), 65: 2261-2265, 1990.
17. Zeid, N. A., and Muller, H. K. S100-positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology, 25: 338-343, 1993.
18. Mayordomo, J. I., Rivera, F., and Cortes-Funes, H. Colony-stimulating factors for adjunctive therapy of infections in neutropenic cancer patients. Support Care Cancer, 3: 84-85, 1995.
19. Toura, J., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T., and Taniguchi, M. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol., 163: 2387-2391, 1999.
20. Cao, X., Zhang, W., Wang, J., Zhang, M., Huanq, X., Hamada, H., and Chen, W. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells. Immunology, 97: 616-625, 1999.
21. Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., and Carbone, D. P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med., 2: 1096-1103, 1996.
22. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., and Carbone, D. P. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 92: 4150-4166, 1998.
23. Gabrilovich, D. I., Ishida, T., Nadaf, S., Ohm, J. E., and Carbone, D. P. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin. Cancer Res., 5: 2963-2970, 1999.
24. Fleming, I. D., Cooper, J. S., Henson, D. E., Hutter, R. P. V., Kennedy, B. J., Murphy, G. P., et al. (eds.), American Joint Committee on Cancer Staging Manual, Ed. 5. Philadelphia: J. B. Lippincott, 1997.
25. Hsu, S. M., Raine, L., and Fanger, H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am. J. Clin. Patrol., 75: 816-821, 1981.
26. Mattern, J., Koomagi, R., and Volm, M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer, 73: 931-934, 1996.
27. Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K., Overholser, J., Hooper, A., Pytowski, B., Witte, L., Bohlen, P., and Hicklin, D. J. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res., 59: 5209-5218, 1999.
28. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Wash. DC), 246: 1306-1309, 1989.
29. Takanami, I., Takeuchi, K., and Naruke, M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer (Phila.), 88: 2686-2692, 2000.
30. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., and Harris, A. L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res., 56: 4625-4629, 1996.
31. Lipponen, P. K., Eskelinen, M. J., Jauhianen, K., Harju, E., and Terho, R. Tumor infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur. J. Cancer, 29A: 187-188, 1993.
32. Shimizu, J., Zou, J. P., Ikegame, K., Katagiri, T., Fujiwara, H., and Hamaoka, T. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. J. Immunol., 146: 1708-1714, 1991.
33. Furukawa, T., Watanabe, S., Sato, Y., Kodama, T., Nakajima, T., and Shimosato, Y. Heterogeneity of histiocytes in primary lung cancer stained with anti-S100 protein, lysozyme and OKT6 antibodies. Jpn. J. Clin. Oncol., 14: 647-657, 1984.
34. Banchereau, J., and Steinmen, R. M. Dendritic cells and the control of immunity. Nature (Lond.), 392: 245-252, 1998.
35. Saito, H., Tsujitani, S., Ikeguchi, M., Maeta, M., and Kaibara, N. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br. J. Cancer, 78: 1573-1577, 1998.